390 related articles for article (PubMed ID: 23470164)
1. Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis.
Bergmann KR; Liu SX; Tian R; Kushnir A; Turner JR; Li HL; Chou PM; Weber CR; De Plaen IG
Am J Pathol; 2013 May; 182(5):1595-606. PubMed ID: 23470164
[TBL] [Abstract][Full Text] [Related]
2. Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model.
Ling X; Linglong P; Weixia D; Hong W
PLoS One; 2016; 11(8):e0161635. PubMed ID: 27551722
[TBL] [Abstract][Full Text] [Related]
3. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis.
Khailova L; Dvorak K; Arganbright KM; Halpern MD; Kinouchi T; Yajima M; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2009 Nov; 297(5):G940-9. PubMed ID: 20501441
[TBL] [Abstract][Full Text] [Related]
4. Necrotizing enterocolitis leads to disruption of tight junctions and increase in gut permeability in a mouse model.
Ravisankar S; Tatum R; Garg PM; Herco M; Shekhawat PS; Chen YH
BMC Pediatr; 2018 Nov; 18(1):372. PubMed ID: 30482190
[TBL] [Abstract][Full Text] [Related]
5. Intestinal alkaline phosphatase administration in newborns is protective of gut barrier function in a neonatal necrotizing enterocolitis rat model.
Rentea RM; Liedel JL; Welak SR; Cassidy LD; Mayer AN; Pritchard KA; Oldham KT; Gourlay DM
J Pediatr Surg; 2012 Jun; 47(6):1135-42. PubMed ID: 22703783
[TBL] [Abstract][Full Text] [Related]
6. Necrotizing enterocolitis in a mouse model leads to widespread renal inflammation, acute kidney injury, and disruption of renal tight junction proteins.
Garg PM; Tatum R; Ravisankar S; Shekhawat PS; Chen YH
Pediatr Res; 2015 Nov; 78(5):527-32. PubMed ID: 26270572
[TBL] [Abstract][Full Text] [Related]
7. Caveolin 1 is Associated with Upregulated Claudin 2 in Necrotizing Enterocolitis.
Ares G; Buonpane C; Sincavage J; Yuan C; Wood DR; Hunter CJ
Sci Rep; 2019 Mar; 9(1):4982. PubMed ID: 30899070
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model.
Caplan MS; Miller-Catchpole R; Kaup S; Russell T; Lickerman M; Amer M; Xiao Y; Thomson R
Gastroenterology; 1999 Sep; 117(3):577-83. PubMed ID: 10464133
[TBL] [Abstract][Full Text] [Related]
9. Intestinal barrier dysfunction in human necrotizing enterocolitis.
Moore SA; Nighot P; Reyes C; Rawat M; McKee J; Lemon D; Hanson J; Ma TY
J Pediatr Surg; 2016 Dec; 51(12):1907-1913. PubMed ID: 27720222
[TBL] [Abstract][Full Text] [Related]
10. Intestinal epithelial tight junctions and permeability can be rescued through the regulation of endoplasmic reticulum stress by amniotic fluid stem cells during necrotizing enterocolitis.
Li B; Lee C; Chuslip S; Lee D; Biouss G; Wu R; Koike Y; Miyake H; Ip W; Gonska T; Pierro A
FASEB J; 2021 Jan; 35(1):e21265. PubMed ID: 33373067
[TBL] [Abstract][Full Text] [Related]
11. Rho kinase inhibition maintains intestinal and vascular barrier function by upregulation of occludin in experimental necrotizing enterocolitis.
Grothaus JS; Ares G; Yuan C; Wood DR; Hunter CJ
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G514-G528. PubMed ID: 29927318
[TBL] [Abstract][Full Text] [Related]
12. Role of lactadherin in intestinal barrier integrity in experimental neonatal necrotizing enterocolitis.
Shen H; Lei Y; He X; Liu D; He Z
J Cell Biochem; 2019 Dec; 120(12):19509-19517. PubMed ID: 31265168
[TBL] [Abstract][Full Text] [Related]
13. Changes in hepatic cell junctions structure during experimental necrotizing enterocolitis: effect of EGF treatment.
Khailova L; Dvorak K; Arganbright KM; Williams CS; Halpern MD; Dvorak B
Pediatr Res; 2009 Aug; 66(2):140-4. PubMed ID: 19390485
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan 35 kDa enhances epithelial barrier function and protects against the development of murine necrotizing enterocolitis.
Gunasekaran A; Eckert J; Burge K; Zheng W; Yu Z; Kessler S; de la Motte C; Chaaban H
Pediatr Res; 2020 Jun; 87(7):1177-1184. PubMed ID: 31499514
[TBL] [Abstract][Full Text] [Related]
15. Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury.
Shiou SR; Yu Y; Guo Y; He SM; Mziray-Andrew CH; Hoenig J; Sun J; Petrof EO; Claud EC
PLoS One; 2013; 8(5):e65108. PubMed ID: 23717690
[TBL] [Abstract][Full Text] [Related]
16. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
Clark JA; Doelle SM; Halpern MD; Saunders TA; Holubec H; Dvorak K; Boitano SA; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide decreases inflammation and tight junction disruption in experimental necrotizing enterocolitis.
Seo S; Miyake H; Alganabi M; Janssen Lok M; O'Connell JS; Lee C; Li B; Pierro A
J Pediatr Surg; 2019 Dec; 54(12):2520-2523. PubMed ID: 31668399
[TBL] [Abstract][Full Text] [Related]
18. Conditioned medium from Bifidobacteria infantis protects against Cronobacter sakazakii-induced intestinal inflammation in newborn mice.
Weng M; Ganguli K; Zhu W; Shi HN; Walker WA
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G779-87. PubMed ID: 24627567
[TBL] [Abstract][Full Text] [Related]
19. Apical-Out Enteroids as an Innovative Model for Necrotizing Enterocolitis.
Liebe H; Schlegel C; Cai X; Golubkova A; Loerke C; Leiva T; Hunter CJ
J Surg Res; 2023 Mar; 283():1106-1116. PubMed ID: 36915002
[TBL] [Abstract][Full Text] [Related]
20. Review of claudin proteins as potential biomarkers for necrotizing enterocolitis.
Griffiths V; Al Assaf N; Khan R
Ir J Med Sci; 2021 Nov; 190(4):1465-1472. PubMed ID: 33492576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
